IVD Market to Experience Exponential Growth by 2023 - PowerPoint PPT Presentation

View by Category
About This Presentation

IVD Market to Experience Exponential Growth by 2023


Global IVD Market accounted for $61,103 million in 2016, and is estimated to reach at $84,647 million by 2023, growing at a CAGR of 4.6% from 2017 to 2023. In vitro diagnostic is used to detect any kind of infection and diseases by taking the specimen from the human body to cure diseases or its sequelae. These IVD products can be instruments, reagents, or any system used for the diagnosis of diseases. Request sample copy of this report at: – PowerPoint PPT presentation

Number of Views:8


Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: IVD Market to Experience Exponential Growth by 2023

Opportunity Analysis and Industry Forecast,
IVD Market
Global Opportunity Analysis and Industry
Forecast, 2017-2023
No. of Pages 240 Publish Sep 2017
IVD Market
North America dominated the market, with highest
share in 2016, and is expected to maintain the
lead during the analysis period. However,
Asia-Pacific is expected to grow with the highest
CAGR, owing to significant increase in the number
of well-equipped hospitals with advanced
healthcare systems to cater to the needs of the
large patient population. - Eswar Prasad
IVD Market Overview
  • Global IVD Market accounted for 61,103 million
    in 2016, and is estimated to reach at 84,647
    million by 2023, growing at a CAGR of 4.6 from
    2017 to 2023. 
  • In vitro diagnostics field has evolved with
    technological advancements in the diagnostic
    techniques and awareness about healthcare in the
    emerging market.
  • Increase in incidence of chronic and infectious
    diseases and increase in geriatric population
    drive the global IVD market.
  • In addition, growth in the number of public and
    private diagnostic centers, and point of caring
    centers is expected to fuel the market during the
    analysis period.

IVD Market Report Key Benefits
  • The study provides in-depth analysis of the
    global IVD market along with current trends and
    future estimations to elucidate the imminent
    investment pockets.
  • Quantitative analysis of the industry is provided
    for the period of 2016-2023 to enable the
    stakeholders to capitalize on the prevailing
    market opportunities.
  • Extensive analysis by technology and application
    helps understand various trends and prevailing
    opportunities in the market.
  • Comprehensive analysis of all geographical
    regions is provided, which determines the main
    opportunities in these geographies.
  • The key market players are profiled and their
    strategies are analyzed to predict the
    competitive outlook of the market.

IVD Market Report Key Findings
  • The reagents segment dominated the market in
    2016, and is projected to grow at the 3.7 CAGR.
  • The immunodiagnostics segment accounted for the
    highest share of in 2016.
  • The infectious diseases segment was the major
    shareholder in the Asia-Pacific IVD based
    application market in 2016.
  • The standalone laboratory segment accounted for
    the highest share of in 2016.
  • North America was the major shareholder of global
    IVD market in 2016.

IVD Market Segments
IVD Market Segments
By End Users
By End Users
By Product Type
By Application
By Techniques
IVD Market By Product Type
IVD Market By Technique
IVD Market By Geography
  • North America, Europe, Asia-Pacific, LAMEA

Key Players in Industry
  • Thermo Fisher Scientific Inc.
  • Alere Inc.
  • Biomerieux
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Becton Dickinson and Company
  • Bio-Rad Laboratories
  • Bayer AG
  • Sysmex Corporation
  • Johnson Johnson
  • Download Sample Copy of this Report Click Here

Thank You! For More Details
Visit us at
Follow Us On
About PowerShow.com